Clinical Trial Update: A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816) [Phase 1]

View source ↗

Summary

A completed Phase 1 safety and tolerability trial of SCH 721015 in patients with bladder cancer (transitional cell carcinoma of the bladder).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• SCH 721015

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bladder Neoplasms | Phase 1 | Status: COMPLETED